JASON NALL: Open Payments
NPI 1841607363 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 12 payments from 7 companies in 2025. Trend: 2023 $205 · 2024 $402 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $65 |
| PFIZER INC. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Novo Nordisk Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: VYNDAQEL, CAMZYOS, CARDIOMEMS, LEQVIO, GALLANT, Wegovy, Kerendia, WAINUA.
Industry payments across CT — which companies pay providers there.
